Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Expression of beclin 1 in non-small cell lung cancer: an immunohistochemical study.

Lv ZQ, Han JJ, Liu YQ, Wang LL, Tang QL, Sun Q, Li HG.

Clin Respir J. 2015 Jul;9(3):359-65. doi: 10.1111/crj.12148. Epub 2014 May 15.

PMID:
24720835
2.

Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.

Wang X, Du Z, Li L, Shi M, Yu Y.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10644-52. eCollection 2015 Sep 1.

3.

Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.

Li YY, Lam SK, Mak JC, Zheng CY, Ho JC.

Lung Cancer. 2013 Sep;81(3):354-61. doi: 10.1016/j.lungcan.2013.05.012. Epub 2013 Jun 13.

PMID:
23769318
4.

Expression of ER stress and autophagy-related molecules in human non-small cell lung cancer and premalignant lesions.

Kim KM, Yu TK, Chu HH, Park HS, Jang KY, Moon WS, Kang MJ, Lee DG, Kim MH, Lee JH, Chung MJ.

Int J Cancer. 2012 Aug 15;131(4):E362-70. doi: 10.1002/ijc.26463. Epub 2011 Nov 9.

5.

Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.

Jiang L, Liang X, Liu M, Wang W, Ma J, Guo Q, Han L, Yang C, Nan K.

Oncol Rep. 2014 Nov;32(5):1931-8. doi: 10.3892/or.2014.3432. Epub 2014 Aug 21.

PMID:
25175672
6.

Autophagy and Bcl-2/BNIP3 death regulatory pathway in non-small cell lung carcinomas.

Karpathiou G, Sivridis E, Koukourakis M, Mikroulis D, Bouros D, Froudarakis M, Bougioukas G, Maltezos E, Giatromanolaki A.

APMIS. 2013 Jul;121(7):592-604. doi: 10.1111/apm.12026. Epub 2012 Dec 8.

PMID:
23216071
7.

[Relationship between mutations of epidermal growth factor receptor gene and clinicopathologic features of non-small cell lung cancers].

Wang F, Fu S, Tang T, Deng L, Zhang X, Li YZ, Shao JY.

Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):664-6. Chinese.

PMID:
22321543
8.

[Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].

Fan MJ, Li HG, Lü ZQ, Zhang HZ, Shen XM.

Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):679-82. Chinese.

PMID:
22321547
9.

Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.

Sonobe M, Nakagawa M, Takenaka K, Katakura H, Adachi M, Yanagihara K, Otake Y, Wada H, Tanaka F.

J Surg Oncol. 2007 Jan 1;95(1):63-9.

PMID:
17192868
10.
11.

High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.

Sun PL, Seol H, Lee HJ, Yoo SB, Kim H, Xu X, Jheon S, Lee CT, Lee JS, Chung JH.

J Thorac Oncol. 2012 Feb;7(2):323-30. doi: 10.1097/JTO.0b013e3182381515.

12.

Autophagic protein Beclin 1 serves as an independent positive prognostic biomarker for non-small cell lung cancer.

Zhou W, Yue C, Deng J, Hu R, Xu J, Feng L, Lan Q, Zhang W, Ji D, Wu J, Liu Q, Liu A.

PLoS One. 2013 Nov 15;8(11):e80338. doi: 10.1371/journal.pone.0080338. eCollection 2013 Nov 15.

13.

[Epidermal growth factor receptor gene mutations and clinicopathologic correlation in 309 patients with non-small cell lung cancer].

Feng Q, Li XH, Chen Z, He JS, Wang CX, Zhou LX, Xue WC.

Zhonghua Bing Li Xue Za Zhi. 2011 Oct;40(10):660-3. Chinese.

PMID:
22321542
14.

High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.

Mochinaga K, Tsuchiya T, Nagasaki T, Arai J, Tominaga T, Yamasaki N, Matsumoto K, Miyazaki T, Nanashima A, Hayashi T, Tsukamoto K, Nagayasu T.

Clin Lung Cancer. 2014 Mar;15(2):136-144.e4. doi: 10.1016/j.cllc.2013.09.002. Epub 2013 Nov 14.

PMID:
24405586
15.

EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance.

Wei Y, Zou Z, Becker N, Anderson M, Sumpter R, Xiao G, Kinch L, Koduru P, Christudass CS, Veltri RW, Grishin NV, Peyton M, Minna J, Bhagat G, Levine B.

Cell. 2013 Sep 12;154(6):1269-84. doi: 10.1016/j.cell.2013.08.015.

16.

Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the "Hispanic paradox".

Arrieta O, Ramírez-Tirado LA, Báez-Saldaña R, Peña-Curiel O, Soca-Chafre G, Macedo-Perez EO.

Lung Cancer. 2015 Nov;90(2):161-6. doi: 10.1016/j.lungcan.2015.08.010. Epub 2015 Aug 22.

PMID:
26358312
17.

[Expression of autophagy-related genes Beclin1 and MAPLC3 in non-small cell lung cancer].

Liu Q, Wang JJ, Pan YC, Meng LF, Zhan X, Zheng QF.

Ai Zheng. 2008 Jan;27(1):25-9. Chinese.

PMID:
18184459
18.

Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure.

Arrieta O, Campos-Parra AD, Zuloaga C, Avilés A, Sánchez-Reyes R, Manríquez ME, Covián-Molina E, Martínez-Barrera L, Meneses A, Cardona A, Borbolla-Escoboza JR.

J Thorac Oncol. 2012 Aug;7(8):1228-34. doi: 10.1097/JTO.0b013e3182582a93.

20.

Supplemental Content

Support Center